# Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study)

Study · id `cardio:ct-nct06945809` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06945809](<https://clinicaltrials.gov/study/NCT06945809>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06945809

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 216 participants.

## Technical summary

Registry record NCT06945809. Randomized; no masking; primary purpose treatment. Start 2026-07-13 (actual); primary completion 2028-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 216 participants (planned count; ClinicalTrials.gov record NCT06945809, source copy `cardio:ctgov-nct06945809-2026-08-26`, retrieved 2026-11-18)
- Started: 2026-07-13 (actual) (ClinicalTrials.gov record NCT06945809, source copy `cardio:ctgov-nct06945809-2026-08-26`, retrieved 2026-11-18)
- Primary completion: 2028-10 (anticipated) (ClinicalTrials.gov record NCT06945809, source copy `cardio:ctgov-nct06945809-2026-08-26`, retrieved 2026-11-18)
- Completion: 2032-10 (anticipated) (ClinicalTrials.gov record NCT06945809, source copy `cardio:ctgov-nct06945809-2026-08-26`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT06945809, source copy `cardio:ctgov-nct06945809-2026-08-26`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06945809-2026-08-26`, retrieved 2026-11-18)

## The registry's words

- Brief title: Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study)
- Acronym: Gallant
- Condition: Aortic Dissection
- Condition: Distal Entry Tear
- Intervention (Device): WeFlow-EndoPatch Aortic Endovascular Patch System
- Intervention (Other): Conventional Treatment group
- Lead sponsor: Hangzhou Endonom Medtech Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic dissection (`cardio:aortic-dissection`)

## Provenance

Content hash: 0a1044c33be4b4e9c13b3f041d656930a6c1aea79ed5a51b2ac6f560d61f4ab1
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
